Implandata Ophthalmic Products has begun a clinical study of its novel pressure sensor for continual monitoring of IOP in glaucoma, according to a press release.
The first patient has been implanted with the suprachoroidal-placed Eyemate-SC sensor in the international, multicenter, first-in-human ARGOS-SC01 study, the release said.
The Eyemate-SC is intended for implantation in glaucoma patients who do not need cataract surgery. The Eyemate-IO, which is intended for use in glaucoma patients who are undergoing cataract surgery, already has a CE mark.
“The successful inclusion of the first
Uncategorized